Kim SJ, Kim BJ, Kang H. Measurement of biological age may help to assess the risk of colorectal adenoma in screening colonoscopy. World J Gastroenterol 2017; 23(37): 6877-6883 [PMID: 29085230 DOI: 10.3748/wjg.v23.i37.6877]
Corresponding Author of This Article
Beom Jin Kim, MD, PhD, Associate Professor, Department of Internal Medicine, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, South Korea. kimbj@cau.ac.kr
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 7, 2017; 23(37): 6877-6883 Published online Oct 7, 2017. doi: 10.3748/wjg.v23.i37.6877
Table 1 Baseline characteristics of the subjects
All subjects (n = 2696)
Chronological age
Biological age
Age [median (P25-P75), yr]
46.0 (39.0-54.0)
44.7 (38.2-53.1)
Gender
Male
1876
(69.6)
Female
820
(30.4)
High blood pressure
Yes (%)
544
(20.2)
No (%)
2152
(79.8)
Total cholesterol (mg/dL)
193.00
(172.00-217.75)
LDL cholesterol (mg/dL)
118.00
(99.00-141.00)
HDL cholesterol (mg/dL)
53.00
(45.0-64.00)
Triglyceride (mg/dL)
98.00
(66.00-152.00)
Fasting glucose (mg/dL)
85.00
(79.00-92.00)
HbA1c
5.40
(5.20-5.70)
CEA
1.55
(1.00-2.38)
Metabolic syndrome
Yes
218
(8.1)
No
2478
(91.9)
Table 2 Characteristics of colorectal adenoma in subjects n (%)
All subjects (n = 2696)
Colorectal adenoma
Yes
622 (23.1)
No
2074 (76.9)
Location
Proximal
489 (18.1)
Distal
244 (9.1)
Both
53 (2.0)
Size (mm)
< 10
714 (26.5)
≥ 10
73 (2.7)
Number
1
484 (18.0)
≥ 2
138 (5.1)
Table 3 Clinical characteristics between biological age-dominant and chronological age-dominant groups
BA-dominant group (n = 28)
CA-dominant group (n = 76)
P value
Age (yr, mean ± SD)
42.00 (35.25-49.75)
52.00 (43.25-59.00)
0.001
Gender
0.013
Male
25 (89.3)
49 (64.5)
Female
3 (10.3)
27 (35.5)
High blood pressure
< 0.001
Yes (%)
11 (39.3)
6 (7.9)
No (%)
17 (60.7)
70 (92.1)
Fasting glucose (mg/dL)
88.00 (82.00-97.50)
81.00 (75.25-87.00)
< 0.001
HbA1c
5.55 (5.30-5.80)
5.30 (5.20-5.50)
0.001
CEA
1.91 (0.97-3.20)
1.67 (1.03-2.57)
0.858
Metabolic syndrome
< 0.001
Yes
7 (25.0)
1 (1.3)
No
21 (75.0)
75 (98.7)
Table 4 Colorectal adenoma between biological age-dominant and chronological age-dominant groups n (%)
BA-dominant group
CA-dominant group
P value
(n = 28)
(n = 76)
Colorectal adenoma
0.386
Yes
3 (10.7)
15 (19.7)
No
25 (89.3)
61 (80.3)
Location
0.034
Proximal
0 (0.0)
18 (23.7)
Distal
4 (14.3)
6 (7.9)
Both
1 (3.6)
1 (1.3)
Size (mm)
0.088
< 10
3 (10.7)
23 (30.3)
≥ 10
2 (7.1)
2 (2.6)
Number
0.433
1
2 (7.1)
13 (17.1)
≥ 2
1 (3.6)
2 (2.6)
Citation: Kim SJ, Kim BJ, Kang H. Measurement of biological age may help to assess the risk of colorectal adenoma in screening colonoscopy. World J Gastroenterol 2017; 23(37): 6877-6883